President - Diag & Spatial Bi

PRESIDENT, PROTEIN SCIENCES

Director

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Institution	Shares	Value	Change
Vanguard	18,147,697	$1.3B	INCREASED
BlackRock	14,025,816	$991M	INCREASED
FMR	12,794,784	$904M	INCREASED
Goldman Sachs	7,343,324	$519M	INCREASED
Hbk Investments L P	6,825,000	$482M	NEW

Insider	Type	Shares	Date
Steven C. Crouse (President - Diag & Spatial Bi)	AWARD	14,140	2026-08-17
Steven C. Crouse (President - Diag & Spatial Bi)	AWARD	8,702	2026-08-17
William Geist (PRESIDENT, PROTEIN SCIENCES)	AWARD	23,985	2026-08-17
William Geist (PRESIDENT, PROTEIN SCIENCES)	AWARD	14,762	2026-08-17
Amy E. Herr (Director)	AWARD	1,381	2026-08-17

Bio-Techne Corp. (TECH) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades